Recent publications on Cancer

Holman A, Kross E, Crothers K, Cole A, Wernli K, Triplette M. Patient perspectives on longitudinal adherence to lung cancer screening. Chest. 2022 Jul;162(1):230-241. doi: 10.1016/j.chest.2022.01.054. Epub 2022 Feb 8. PubMed

Sarma EA, Thompson MJ, Bowles EJA, Burnett-Hartman AN, Hubbard RA, Yu O, Chubak J. Patient and tumour characteristics of screening-age adults diagnosed with screen-detected versus symptomatic colon cancer. Colorectal Dis. 2022 Jun 23. doi: 10.1111/codi.16232. PubMed

Lawson MB, Bissell MCS, Miglioretti DL, Eavey J, Chapman CH, Mandelblatt JS, Onega T, Henderson LM, Rauscher GH, Kerlikowske K, Sprague BL, Bowles EJA, Gard CC, Parsian S, Lee CI. Multilevel factors associated with time to biopsy after abnormal screening mammography results by race and ethnicity. JAMA Oncol. 2022 Aug 1;8(8):1115-1126. doi: 10.1001/jamaoncol.2022.1990. PubMed

Wernli KJ, Smith RE, Henderson LM, Zhao W, Durham DD, Schifferdecker K, Kaplan C, Buist DSM, Kerlikowske K, Miglioretti DL, Onega T, Alsheik NH, Sprague BL, Jackson-Nefertiti G, Budesky J, Johnson D, Tosteson ANA. Decision quality and regret with treatment decisions in women with breast cancer: pre-operative breast MRI and breast density. Breast Cancer Res Treat. 2022 Aug;194(3):607-616. doi: 10.1007/s10549-022-06648-7. Epub 2022 Jun 20. PubMed

Nyante SJ, Abraham L, Aiello Bowles EJ, Lee CI, Kerlikowske K, Miglioretti DL, Sprague BL, Henderson LM. Diagnostic mammography performance across racial and ethnic groups in a national network of community-based breast imaging facilities. Cancer Epidemiol Biomarkers Prev. 2022 Jun 17:OF1-OF10. doi: 10.1158/1055-9965.EPI-21-1379. Online ahead of print. PubMed

Kerlikowske K, Su YR, Sprague BL, Tosteson ANA, Buist DSM, Onega T, Henderson LM, Alsheik N, Bissell MCS, O'Meara ES, Lee CI, Miglioretti DL. Association of screening with digital breast tomosynthesis vs digital mammography with risk of interval invasive and advanced breast cancer. JAMA. 2022 Jun 14;327(22):2220-2230. doi: 10.1001/jama.2022.7672. PubMed

Ananth P, Lindsay M, Nye R, Mun S, Feudtner C, Wolfe J. End-of-life care quality for children with cancer who receive palliative care. Pediatr Blood Cancer. 2022 Sep;69(9):e29841. doi: 10.1002/pbc.29841. Epub 2022 Jun 10. PubMed

Schottinger JE, Jensen CD, Ghai NR, Chubak J, Lee JK, Kamineni A, Halm EA, Sugg-Skinner C, Udaltsova N, Zhao WK, Ziebell RA, Contreras R, Kim EJ, Fireman BH, Quesenberry CP, Corley DA. Association of physician adenoma detection rates with postcolonoscopy colorectal cancer. JAMA. 2022 Jun 7;327(21):2114-2122. doi: 10.1001/jama.2022.6644. PubMed

Barthold D, Yeung K, Lieberman D, Fendrick AM. Comparison of screening colonoscopy rates after positive noninvasive testing for colorectal cancer in states with and without cost-sharing.  JAMA Netw Open. 2022;5(6):e2216910. doi: 10.1001/jamanetworkopen.2022.16910.  PubMed

Ramin C, Gierach GL, Abubakar M, Veiga LHS, Vo JB, Curtis RE, Bowles EJ, Feigelson HS, Buist DSM, de Gonzalez AB, Bodelon C. The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems. Cancer Causes Control. 2022 Jul;33(7):1019-1023. doi: 10.1007/s10552-022-01589-4. Epub 2022 May 18. PubMed

Lee JK, Lam AY, Jensen CD, Marks AR, Badalov J, Layefsky E, Kao K, Ho NJ, Schottinger JE, Ghai NR, Carlson CM, Halm EA, Green B, Li D, Corley DA, Levin TR. Impact of the COVID-19 pandemic on fecal immunochemical testing, colonoscopy services, and colorectal neoplasia detection in a large United States community-based population. Gastroenterology. 2022 Sep;163(3):723-731.e6. doi: 10.1053/j.gastro.2022.05.014. Epub 2022 May 14. PubMed

Henrikson NB, Anderson ML, Dickerson J, Ewing JJ, Garcia R, Keast E, King DA, Lewis C, Locher B, McMullen C, Norris CM, Petrik AF, Ramaprasan A, Rivelli JS, Schneider JL, Shulman L, Tuzzio L, Banegas MP. The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship. Trials. 2022 May 13;;23(1):402. doi: 10.1186/s13063-022-06344-3. PubMed

Lawson MB, Herschorn SD, Sprague BL, Buist DSM, Lee SJ, Newell MS, Lourenco AP, Lee JM. Imaging surveillance options for individuals with a personal history of breast cancer: AJR expert panel narrative review. AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27635. [Epub ahead of print]. PubMed

Chubak J, Lund JL. Noncancer comparators in cancer survivorship studies. Cancer. 2022 May 3. doi: 10.1002/cncr.34253. Online ahead of print. PubMed

Abubakar M, Mullooly M, Nyante S, Pfeiffer RM, Aiello Bowles EJ, Cora R, Bodelon C, Butler E, Butcher D, Sternberg L, Troester MA, Weinmann S, Sherman M, Glass AG, de Gonzalez AB, Gierach GL. Mammographic density decline, tamoxifen response, and prognosis by molecular characteristics of estrogen receptor-positive breast cancer. JNCI Cancer Spectr. 2022 May 2;6(3):pkac028. doi: 10.1093/jncics/pkac028. PubMed

Zeng C, Bastarache LA, Tao R, Venner E, Hebbring S, Andujar JD, Bland ST, Crosslin DR, Pratap S, Cooley A, Pacheco JA, Christensen KD, Perez E, Zawatsky CLB, Witkowski L, Zouk H, Weng C, Leppig KA, Sleiman PMA, Hakonarson H, Williams MS, Luo Y, Jarvik GP, Green RC, Chung WK, Gharavi AG, Lennon NJ, Rehm HL, Gibbs RA, Peterson JF, Roden DM, Wiesner GL, Denny JC. Association of pathogenic variants in hereditary cancer genes with multiple diseases. JAMA Oncol. 2022 Jun 1;8(6):835-844. doi: 10.1001/jamaoncol.2022.0373. PubMed

Lowry KP, Callaway KA, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, Kerlikowske K, Wernli KJ, Kurian AW, Henderson LM, Stout NK. Trends in annual surveillance mammography participation among breast cancer survivors from 2004 to 2016.  J Natl Compr Canc Netw. 2022;20(4):379-386.e9. doi: 10.6004/jnccn.2021.7081.  PubMed

Smith RE, Sprague B, Henderson LM, Kerlikowske K, Miglioretti DL, Buist DSM, Wernli KJ, Onega T, Schifferdecker K, Jackson-Nefertiti G, Johnson D, Budesky J, Tosteson ANA. Breast density knowledge in a screening mammography population exposed to density notification. J Am Coll Radiol. 2022 Mar 24:S1546-1440(22)00248-4. doi: 10.1016/j.jacr.2022.02.025 [Epub ahead of print] PubMed

Bowles EJA, Ramin C, Buist DSM, Feigelson HS, Weinmann S, Veiga LHS, Bodelon C, Curtis RE, Vo JB, Berrington de Gonzalez A, Gierach GL. Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016. Breast Cancer Res Treat. 2022 May;193(1):203-216. doi: 10.1007/s10549-022-06561-z. Epub 2022 Mar 11. PubMed

Ryser MD, Lange J, Inoue LYT, O'Meara ES, Gard C, Miglioretti DL, Bulliard JL, Brouwer AF, Hwang ES, Etzioni RB. Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort. Ann Intern Med. 2022 Mar 1. doi: 10.7326/M21-3577. [Epub ahead of print]. PubMed